Your browser doesn't support javascript.
loading
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma.
van Es, Suzanne C; Brouwers, Adrienne H; Mahesh, Shekar V K; Leliveld-Kors, Annemarie M; de Jong, Igle J; Lub-de Hooge, Marjolijn N; de Vries, Elizabeth G E; Gietema, Jourik A; Oosting, Sjoukje F.
Afiliação
  • van Es SC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Mahesh SVK; Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Leliveld-Kors AM; Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and.
  • de Jong IJ; Department of Urology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and.
  • Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands s.oosting@umcg.nl.
J Nucl Med ; 58(6): 905-910, 2017 06.
Article em En | MEDLINE | ID: mdl-28082434

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Everolimo / Bevacizumab / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Everolimo / Bevacizumab / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article